In 2013, Dr. Maryanne Demasi was investigating the clinical trial data on statins when she learned the raw data had been kept secret, held by a group of researchers called the Cholesterol Treatment Trialists (CTT) out of Oxford University. Here, Demasi explains why such secrecy undermines what she terms "the bedrock of science: contestability and replicability." She also notes the ways the landscape has changed since 2013, opening the door for independent review of the data on statins and other drugs.
Read MoreThe secret life of dataRest Day
Post thoughts to comments.
Comments on 190727
28 Comments